2014 Participating Companies

  • Recommend
  • Tweet
  • Print
  • Email

Below is the list of 2014 participating companies and investors available for One-on-One meetings at the BIO CEO & Investor Conference.

To see a list of the 2014 participating investors, please click here.

 

 

20/20 GeneSystems, Inc.
21st Century Investors
Abbvie Biotech Ventures
Ability Pharmaceuticals
AcelRx Pharmaceuticals, Inc.
Aceras Biomedical
Achillion Pharmaceuticals
Actinium Pharmaceuticals, Inc.
Aduro Biotech
Advanced Cell Technology, Inc.
Advaxis
Aegis Capital Corp.
Affichem USA, Inc.
Affimed Therapeutics AG
Agenus, Inc.
Aisling Capital LLC
Akana Healthcare Capital
Akemi Capital
Alcobra Ltd.
Alexion Pharmaceuticals, Inc.
Almorli Capital
Alnylam Pharmaceuticals
ALS TDI
Altrinsic Global Advisors
AM Pappas & Associates
Amarantus Bioscience, Inc.
American Capital
American Portfolio Advisors
Amici Capital
AmTrust Financial
Anavex Life Sciences Corp.
Anson Group Canada
Anthera Pharmaceuticals, Inc.
AntriaBio, Inc.
Apache Capital Management
Aperture Venture Partners
Apogenix
Aposense
Apricus Biosciences, Inc.
Aradigm Corporation
Arcus Ventures
Arena Pharmaceuticals, Inc.
Arrowhead Research Corporation
Arthritis Foundation
Ascendant Capital
Ascendiant Capital Markets LLC
Ash Stevens, Inc.
Aspire Capital Partners
AstraZeneca
ATEL Ventures
Athersys, Inc.
Athyrium Capital Management
Athyrium Opportunities Advisors LLC
Atika Capital Management, LLC
Atlantis Investment
Atlas Capital
ATP Early Harvest Fund
AUM Lifetech, Inc.
Auriga Capital Management
Auxilium Pharmaceuticals, Inc.
Avet Capital Management
Avior Capital
AZCA Venture Partners
Bank of America Merrill Lynch
Barclays
Bavarian Nordic, A/S
Bawcap
Baxter Ventures
Bayshore venture
BCO Pharma
BDC Healthcare Fund
BEAT Biotherapeutics Corp.
Beigene
Benitec Biopharma
Bergmor Capital
Bijan Capital
Bill and Melinda Gates Foundation
BIND Therapeutics
Biocom
BioCrea
Biodel, Inc.
BioLineRx
BioMaryland Center
BioMed Ventures
BioPharm Insight
Biotech Stock Review
Biotie Therapies Corp.
BioXcel Corporation
BioYields
Bishop Capital Management
Black Diamond
Blaise Group International
Bloom Burton & Co.
Bluelane Capital
BMNova llc
BNY Mellon
BofAML
Boodell & Co.
Brean Capital
Brinson Patrick Securities Corporation
Bristol-Myers Squibb
Brookside Capital Partners Fund, LP
Burrage Capital
Burrill & Company
Business Wire
BVF Partners
Cancer Genetics, Inc.
Cantor Fitzgerald
Capital Royalty
Catalyst Pharmaceutical Partners, Inc.
Cato BioVentures
Caxton Alternative Management LP
Cedarlane Enterprises inc
Cedrus Investments
Celator Pharmaceuticals, Inc.
CEL-SCI Corporation
Celsus Therapeutics PLC
Cempra, Inc.
Cerecor, Inc.
Chelsea Financial Services
Chimerix
China Private Equity Group
Chubb Group of Insurance Companies
Cleveland Biolabs, Inc.
Codexis, Inc.
Columbia Laboratories, Inc.
Compliance Implementation Services (CIS)
Conatus Pharmaceuticals, Inc.
Connectis Ventures
Cordlife Group Ltd.
Cortina Asset Management
Covagen AG
Cowen Group
Crede Capital Group
Critical Mass Partners
Cross Current Research LLC
Crown Point Group
CRT
Cubist Pharmaceuticals
Cyclacel Pharmaceuticals, Inc.
CymaBay Therapeutics
CytoDyn Inc.
Cytokinetics
Cytos Biotechnology Ltd.
CytRx Corporation
Dabar Investment Associates
Dalek Capital Management, LLC
DARA BioSciences, Inc.
Deerfield Management
Deerfield Management Company LP
DelMar Pharmaceuticals, Inc.
Delwar Capital
Denovo Biomarkers
DiaMedica, Inc.
Dicerna Pharmaceuticals, Inc.
Direct Markets
DLS Research
Douglas C. Lane & Associates, Inc
DSM Capital Partners
Eachwin Capital LP
Early Harvest Fund
Easton Capital Investment Group
EcoR1 Capital
Edgewood Management LLC
Edison Investment Research
EGB Advisors, LLC
EMD Serono, Inc.
Emerald Advisers, Inc.
Empire Asset Management
Ennovance Capital 
Enso Ventures
EntreMed, Inc.
Epilepsy Foundation of America
EPISTAT
Epizyme
Equisolve LLC
Etubics Corporation
Euro am Sonntag, finanzen.net
Euroscreen SA
Exelixis
Expression Diagnostics, Inc. (XDx)
F.B.Asset Management
Favus Institutional Research LLC
Fenwick & West LLP
FireRock Capital
First Island Capital
First Manhattan Co.
First Report Managed Care
Five Corners Capital Inc.
Five Prime Therapeutics, Inc.
FMB Research
Forest Laboratories, Inc.
Fountain Healthcare Partners
Fresenius Medical Care NA
Gagnon Securities
Galectin Therapeutics, Inc.
Galena Biopharma
GE Capital, Life Science Finance
Gem Partners
Genesis Pharma S.A.
Genfit Corporation
GenSpera, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline
Global Corporate Finance
Global Energy Capital LLC
GlobeImmune, Inc.
GlycoMimetics, Inc.
Goldman Sachs
Greenwich LifeSciences
Greywall Asset Management
Griffin Securities
GTx, Inc.
Guggenheim Partners
H.C. Wainwright & Co., LLC
H. Lee Moffitt Cancer Center
Halcyon Cabot Partner, LLC
Health Enhancement Products, Inc.
HealthCor Management
HealthFirst
Heat Biologics, Inc.
Heptares Therapeutics Ltd.
Hercules Technology Growth Capital, Inc.
HI Investors Capital
HK & Associates
Horizon Pharma
Horizon Technology Finance
Hutchin Hill Capital
iCo Therapeutics, Inc.
Idera Pharmaceuticals
IGC
IGNYTA, Inc.
Iliad Ventures LLC
Immatics Biotechnologies
Immune Design
Immune Pharmaceuticals
ImmunoCellular Therapeutics
Immunocore
Immunovaccine, Inc.
Immupharma Plc
Informa Business Information
IN VIVO/ The Pink Sheet
Inova Software, Inc.
Innovus Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
InSymbiosis
Intarcia Therapeutics
Integra LifeSciences
Intra-Cellular Therapies, Inc.
Intrexon Corporation
Ironridge Global Partners, LLC
IS Ceske Sporitelny
Isarna Therapeutics GmbH
ISI Group
ISPAT
Issaquena Trust
J.D. Kleinke
JDRF
Jefferies LLC
Jina Ventures, Inc.
JMP Securities LLC
Johnston Associates
JP Morgan
JT Pharma
Kadmon Pharmaceuticals, Inc.
Kadmon Corporation
Kalex Capital, LLC
KaloBios Pharmaceuticals, Inc.
Kanglaite USA
Kareg Research/ Double U Fund
Karo Bio
Katz Associates
KemPharm, Inc.
Keryx Biopharmaceuticals, Inc.
Kids v Cancer
Kimberly-Clark
Kissei America, Inc.
Knoll Capital Management, LLC
Korea-Seoul Life Science Fund (KSLSF)
Kowa Research Institute
La Jolla Pharmaceutical Company
Ladenburg Thalmann
Laidlaw & Company
Landmark Angels, Inc.
Lazard
Leerink Partners, LLC
Lexicon Pharmaceuticals, Inc.
Lexington Capital Management
LFP Capital
Life Science Leader
 
Life Science Ventures
LifeSci Advisors
LifeScience EquityPartners, LLC
LifeTech Capital
Lincoln Park Capital 
Little Gem Life Sciences
Livingston Securities
Loeb King Capital Management
Loeb Partners
Logical Ventures
Loncar Family
Long Wharf Investors, Inc.
Loxo Oncology
LSWorks LLC
Lumena Pharmaceuticals
Lumira Capital
Magna Group Capital
Marina Biotech
Markston International LLC
Maryland Dept. of Bus.& Economic Development/Maryland Venture Fund
Mast Therapeutics, Inc.
MaxCyte, Inc.
Maxim Group, LLC
Maz Capital Advisors
Medicenna Therapeutics, Inc.
Medimmune Ventures, Inc.
MedPanel Capital Advisors
MedPro Investors LLC
Mehta Partners
Melanoma Research Alliance
Melinta Therapeutics, Inc.
Memorial Sloan-Kettering Cancer Center
MenoGeniX, Inc.
Mercadyne Investments, LLC
Merck & Co.
Merck KGaA
Merck Serono SA
Merlin Nexus
Mesoblast, Inc.
MetaStat, Inc.
MFP Investors
Mid Atlantic Bio Angels
Midfarm Capital LLC
Mintz Levin
Mirna Therapeutics, Inc.
Mitchell & Sullivan Capital 
Mitsubishi Tanabe Pharma America
Mitsui Global Investment
Mizuho Securities
MLV & Co.
Monness Crespi Hardt
Morgan Stanley
Morrison & Foerster, LLP
MorphoSys AG
Mountain Brook Capital Management LLC
MP Healthcare Venture Management, Inc.
MSF Capital Advisors
Muse Capital LLP
MVP Capital Partners
N8 Medical
Navidea Biopharmaceuticals
Needham & Company
NeoStem, Inc.
Neuralstem, Inc.
NeuroLifeSciences
New Enterprise Associates
New Leaf Venture Partners
Newron Pharmaceuticals, SpA
New York BIO
NexImmune
NGN Capital
NIH/NINDS
Nivarta, Inc.
NJ Investment Division
Nora Therapeutics, Inc.
Nordcon Capital
Northwest Biotherapeutics, Inc.
Norumbega Capital
NovaBay Pharmaceuticals, Inc.
Novartis Pharmaceuticals
Novavax, Inc.
Novelos Therapeutics, Inc.
Nowak Ventures LLC
NSIP LLC
Numoda Capital Innovations
Nuron Biotech, Inc.
Oak Ridge Investments LLC
Ohr Pharmaceutical
OncoMed Pharmaceuticals
OnconovaTherapeutics, Inc.
OncoSec Medical, Inc.
On-Point Capital, LLC
Opaleye Management
Opexa Therapeutics
Ophthotech Corporation
Oppenheimer & Co. Inc.
Opsona Therapeutics
Opus Point Partners
Oracle Investment Management
OrbiMed Advisors LLC
Orexigen Therapeutics, Inc.
OvaScience
Oxford Finance LLC
Oxigene
Pacific Rim Ventures
Paion AG
Palatin Technologies, Inc.
Palkon Capital Management
Pappas Ventures
Paras Biopharmaceuticals Finland Oy
PDL BioPharma, Inc.
Perceptive Advisors
Pfizer
Pharmakon
Pieris AG
Pioneer Investments
Piper Jaffray
Pluristem Therapeutics, Inc.
Poliwogg
Polynoma
Priaxon AG
Prima Biomed Ltd.
Probiodrug AG
Profit Investments
Progenics Pharmaceuticals, Inc.
Prolong Pharmaceuticals
ProMed Partners
Promedior
Promethera Biosciences
ProMetic Life Sciences, Inc.
Prophylix Pharma
ProQuest Investments
Prosensa
Prospector Partners
Proteon Therapeutics
pSivida Corp.
Purdue Pharma LP
Quest PharmaTech, Inc.
Questrion
Quogue Capital
QVT Financial
QVT Financial, L.P.
R-Pharm
R.F. Lafferty
RA Capital Management, LLC
Real Endpoints
Regado Biosciences
Regulus Therapeutics, Inc.
Relypsa, Inc.
ReNeuron Group plc
RepliCel Life Sciences, Inc.
Repros Therapeutics, Inc.
Resverlogix
Retrophin, Inc.
Revach Fund LP
Rexahn Pharmaceuticals, Inc.
Rho Ventures
Ricerca Biosciences LLC
Ridgeback Capital Management, LLC
Rigel Pharmaceuticals, Inc.
Robert W. Baird
Rockefeller & Co.
Rocker Funder
Rolin Inc.
Roosevelt Investments
ROTH Capital Partners
Roy Healthcare Research
R-Pharm
RTW Investments
RusBio Ventures
RW Baird
RXi Pharmaceuticals
SAC Capital
Sagient Research Systems
Samtheo Biopharma LLC
Sands Capital
Sanofi
Sanofi-Genzyme BioVentures
Sapidus Investment Advisors
Schroders Investment Management
SciClone Pharmaceuticals
Scottish Development International
Seaside88, LP
Sectoral Asset Management
Selvita
Serrado Capital
Shire
SIGA
SimRx 
Sio Capital Management
Slater Technology Fund
SLC Management
Slone Partners
Small Business Technology Investment Fund
Soligenix
Somerset Capital Group, Ltd.
Sophrosyne Capital
Soros Fund Management LLC
Sorrento Therapeutics, Inc.
Spencer Edwards Investment
Sphera Global Healthcare Fund
Spring Bank Pharmaceuticals
SR One
Stadnyk and Partners
Stallergenes SA
Stanphyl Capital
Stem Cell Therapeutics Corporation
StemCells, Inc.
Stemline Therapeutics, Inc.
Stifel
Strategy Signal LLC
STRH
Stuyvesant Capital Management
Sunrise Equity Partners
SunTrust Robinson Humphrey
Sutro Biopharma
SYGNIS AG
Symphony Capital LLC
Syndax Pharmaceuticals, Inc.
Synergy Pharmaceuticals
Synta Pharmaceuticals
Synthetic Biologics, Inc.
Syzygy Therapeutics
TaiAn Technologies
Taiho Pharmaceutcal Co., Ltd. 
Targacept, Inc.
Targazyme, Inc.
Target Health Inc 
Technological & Investment Horizons
Tecumseh Partners
Tegris Advisors
Tekmira Pharmaceuticals Corporation
Tetraphase Pharmaceuticals, Inc.
Texas Heart Institute
TG Therapeutics, Inc.
The Astrologers Fund
The Channel Group, LLC
The Issaquena Trust
The Keiser Foundation
Thomas, McNerney & Partners
Thomson Reuters 
Tiberend Strategic Advisors, Inc.
TiGenix
Trigemina, Inc.
Tobira Therapeutics, Inc.
TONIX Pharmaceuticals, Inc.
Transition Therapeutics, Inc.
Trevena, Inc.
Tripoint Global Equities
TrovaGene, Inc
Tryphon
TxCell SA
UBS
Ultragenyx
US Steel Pension Fund
V2M Capital 
Valquest Capital Management
Vanguard Group
VAO Partmers
Var2 Pharmaceuticals
venBio
Venrock
Verastem
Veziris Ventures LLC
Viking Therapeutics, Inc.
Vinart Corp Capital Management
Vince & Associates Clinical Research
Visium Asset Management 
VWR International LLC
W.L. Gore & Associates
Watervein Partners, Inc.
WBB Securities LLC
Weiss Multi-Strategy Advisers
Wexford Capital LP
Wingate Capital Management Inc.
WK Mahon & Co.
Wolf Capital Management
World Tech Ventures, LLC
Young Capital Partners
Yuco Management, Inc.
Ziopharm Oncology, Inc.
ZZZ Austin Association

 

 

*As of 2/7/2014